|
Volumn 45, Issue SUPPL. 1, 2002, Pages 13-19
|
Neurobiological findings before and during successful lithium therapy of a patient with 48-hour rapid-cycling bipolar disorder
|
Author keywords
48 hour rapid cycling; Bipolar disorder; Cortisol; Lithium; Sleep
|
Indexed keywords
ALPRAZOLAM;
AMITRIPTYLINE;
CARBAMAZEPINE;
CLOMIPRAMINE;
FLUOXETINE;
FLUSPIRILENE;
LEVOMEPROMAZINE;
LITHIUM CARBONATE;
MELATONIN;
METHYLPHENIDATE;
MIANSERIN;
SULPIRIDE;
TRANYLCYPROMINE;
TRAZODONE;
TRIMIPRAMINE;
VALPROIC ACID;
ZUCLOPENTHIXOL;
ADULT;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
DISEASE COURSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TOLERANCE;
DRUG WITHDRAWAL;
HUMAN;
LITHIUM BLOOD LEVEL;
MALE;
MANIC DEPRESSIVE PSYCHOSIS;
MOOD;
NEUROBIOLOGY;
NEUROENDOCRINOLOGY;
POLYSOMNOGRAPHY;
PRIORITY JOURNAL;
RAPID CYCLING BIPOLAR DISORDER;
RELAPSE;
REMISSION;
SEXUAL DYSFUNCTION;
SLEEP DEPRIVATION;
TREATMENT OUTCOME;
ADULT;
AFFECT;
ANTIMANIC AGENTS;
BIPOLAR DISORDER;
FLUORODEOXYGLUCOSE F18;
HUMANS;
HYDROCORTISONE;
LITHIUM;
MALE;
POLYSOMNOGRAPHY;
PSYCHIATRIC STATUS RATING SCALES;
RADIOPHARMACEUTICALS;
SALIVA;
SLEEP;
THYROTROPIN;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0036121092
PISSN: 0302282X
EISSN: None
Source Type: Journal
DOI: 10.1159/000049256 Document Type: Article |
Times cited : (14)
|
References (26)
|